Richter Syndrome (RS): Genome-Wide Promoter Methylation Profile Differs From De Novo Diffuse Large B-Cell Lymphoma (DLBCL) and Affects Genes Involved in Stem-Cell Maintenance and TP53 Pathway

被引：0
|
作者：
Rossi, Davide [1 ]
Rinaldi, Andrea [2 ]
Kwee, Ivo [2 ]
Arcaini, Luca [3 ]
Lucioni, Marco [4 ]
Gattei, Valter [5 ]
Marasca, Roberto [6 ]
Forconi, Francesco [7 ]
Berger, Francoise [8 ]
Cogliatti, Sergio [9 ]
Zucca, Emanuele [2 ]
Gaidano, Gianluca [1 ]
Bertoni, Francesco [2 ]
机构：
[1] Amedeo Avogadro Univ Eastern Piedmont, Novara, Italy
[2] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland
[3] Univ Pavia, I-27100 Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo Pavia, Pavia, Italy
[5] IRCCS, CRO, Aviano, PN, Italy
[6] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Div Hematol, Modena, Italy
[7] Univ Siena AOUS, Siena, Italy
[8] Univ Lyon 1, Hosp Civils Lyon, Dept Pathol & Hematol, F-69365 Lyon, France
[9] Kantons Spital St Gallen, Dept Pathol, St Gallen, Switzerland
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：597 / 597
页数：1
相关论文
共 19 条
  • [1] Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma
    Rinaldi, Andrea
    Mensah, Afua Adjeiwaa
    Kwee, Ivo
    Forconi, Francesco
    Orlandi, Ester M.
    Lucioni, Marco
    Gattei, Valter
    Marasca, Roberto
    Berger, Francoise
    Cogliatti, Sergio
    Cavalli, Franco
    Zucca, Emanuele
    Gaidano, Gianluca
    Rossi, Davide
    Bertoni, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) : 194 - 204
  • [2] Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome
    Negara, Ivan
    Tomuleasa, Ciprian
    Buruiana, Sanda
    Efremov, Dimitar G.
    CANCERS, 2024, 16 (12)
  • [3] Genome Wide-DNA Profiling of Richter's Syndrome-Diffuse Large B-Cell Lymphoma (RS-DLBCL): Differences with De Novo DLBCL and Possible Mechanisms of Transformation from Chronic Lymphocytic Leukemia
    Bertoni, Francesco
    Scandurra, Marta
    Cerri, Michaela
    Deambrogi, Clara
    Rancoita, Paola M. V.
    Rasi, Silvia
    Forconi, Francesco
    Ponzoni, Maurilio
    Montes-Moreno, Santiago
    Piris, Miguel A.
    Inghirami, Giorgio
    Rinaldi, Andrea
    Zucca, Emanuele
    Kwee, Ivo
    Gaidano, Gianluca
    Rossi, Davide
    BLOOD, 2008, 112 (11) : 720 - 720
  • [4] TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
    Zainuddin, Norafiza
    Berglund, Mattias
    Wanders, Alkwin
    Ren, Zhi-Ping
    Amini, Rose-Marie
    Lindell, Monica
    Kanduri, Meena
    Roos, Goran
    Rosenquist, Richard
    Enblad, Gunilla
    LEUKEMIA RESEARCH, 2009, 33 (01) : 60 - 66
  • [5] TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression
    Symes, Emily
    Wang, Peng
    Lager, Angela M.
    Bishop, Michael R.
    Aqil, Barina
    Venkataraman, Girish
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2735 - 2738
  • [6] Large-Scale Proteomics Identifies Distinct Signatures for Richter Syndrome and De Novo Diffuse Large B-Cell Lymphoma: A French Study from the Filo Group
    Morizot, Romain
    Hergalant, Sebastien
    Piucco, Romain
    Bouclet, Florian
    Quinquenel, Anne
    Dartigeas, Caroline
    Auge, Helene
    Tausch, Eugen
    Lomazzi, Sandra
    Busby, Helene
    Tomowiak, Cecile
    Leblond, Veronique
    Thieblemont, Catherine
    Cymbalista, Florence
    Bene, Marie C.
    Stilgenbauer, Stephan
    Guieze, Romain
    Carapito, Christine
    Perrot, Aurore
    Fornecker, Luc Mathieu
    Feugier, Pierre
    Broseus, Julien
    BLOOD, 2020, 136
  • [7] Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line
    Hsu, Chia-Hsin
    Tomiyasu, Hirotaka
    Liao, Chi-Hsun
    Lin, Chen-Si
    PLOS ONE, 2021, 16 (05):
  • [8] Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease
    Lund, Shelby
    Ngisa, Valentine
    Weber, Kennedee
    Rutz, Alison
    Guidinger, Jinda
    Hartert, Keenan Thomas
    BLOOD RESEARCH, 2022, 57 (02) : 164 - +
  • [9] The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL)
    Young, K. H.
    Moller, M. B.
    Colleoni, G. W. B.
    Sanchez-Beato, A.
    Kerbauy, F. R.
    Leroy, K.
    Piris, M. A.
    Eickhoff, J. C.
    Young, A. H.
    Kanehira, K.
    Cook, S.
    Ranheim, E. A.
    Kahl, B. S.
    Olivier, M.
    Campo, E.
    Delabie, J.
    Gaseoyne, R. D.
    Rosenwald, A.
    Braziel, R. M.
    Jaffe, E. S.
    Wilson, W. H.
    Staudt, L. M.
    Chan, W. C.
    Weasenburger, D. D.
    Greiner, T. C.
    LABORATORY INVESTIGATION, 2007, 87 : 265A - 266A
  • [10] Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
    Xu-Monette, Zijun Y.
    Wu, Lin
    Visco, Carlo
    Tai, Yu Chuan
    Tzankov, Alexander
    Liu, Wei-min
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Zhao, X. Frank
    Choi, William W. L.
    Zhao, Xiaoying
    van Krieken, J. Han
    Huang, Qin
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Zhou, Fan
    Kahl, Brad S.
    Winter, Jane N.
    Xu, Wei
    Li, Jianyong
    Go, Ronald S.
    Li, Yong
    Piris, Miguel A.
    Moller, Michael B.
    Miranda, Roberto N.
    Abruzzo, Lynne V.
    Medeiros, L. Jeffrey
    Young, Ken H.
    BLOOD, 2012, 120 (19) : 3986 - 3996
12